All In MedTech

Company

Lensar

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

LNSR

Nasdaq · LENSAR, Inc.

Public float

$113M

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$58.4M

Fiscal year ending Dec 31, 2025

Net income

-$34.3M

Fiscal year ending Dec 31, 2025

R&D spending

$5.6M

Fiscal year ending Dec 31, 2025

Cash

$12.6M

As of Sep 30, 2026

Long-term debt

$1.9M

As of Sep 30, 2026

Shares outstanding

12.3M

As of Oct 31, 2026

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
May 12, 2023Equity$20.0M$20.0M1Rule 506(b)Form D ↗May 26, 2023
Jul 14, 2014Equity$16.0M$20.0M2Rule 506(b)Form D/A ↗Jan 14, 20152 amendments
Dec 20, 2013Equity$10.0M$10.0M14Rule 506(b)Form D ↗Jan 9, 2014

9 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
LENSAR, Inc.
Headquarters
Orlando, Florida
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
$25,000,001 - $100,000,000
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    9 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Lensar we have 2 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    5 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    1 more trials with a free account

    Reports received

    59

    Received Nov 1, 2025 to Nov 20, 2026. Includes 1 of another or unstated type.

    Malfunction reports

    0

    0.0% of reports

    Injury reports

    58

    98% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230600
    Jan 240600
    Feb 240400
    Mar 240800
    Apr 240400
    May 240500
    Jun 240100
    Jul 240600
    Aug 240300
    Sep 240400
    Oct 240700
    Nov 240900
    Dec 240600
    Jan 250200
    Feb 250200
    Mar 250700
    Apr 250900
    May 250200
    Jun 250400
    Jul 250800
    Aug 250300
    Sep 250400
    Oct 250300
    Nov 250900
    Dec 250600
    Jan 260100
    Feb 260500
    Mar 260800
    Apr 260300
    May 260900
    Jun 260400
    Jul 260800
    Aug 260100
    Sep 260201
    Oct 260200
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.